NeuroSense Therapeutics (NRSN) Current Assets (2020 - 2026)
NeuroSense Therapeutics (NRSN) recorded Current Assets of $844,000 in Q2 2026, down 45.8% from $1.56 million a year earlier.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Current Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, NeuroSense Therapeutics reported Current Assets of $778,000, down 82.3% from FY2024.
- Annual Current Assets has a five-year compound annual growth rate of 0.3% (FY2020 to FY2025).
- Across earlier years, Current Assets came in at $4.4 million in FY2024 (+51.0%), $2.92 million in FY2023 (-60.5%), $7.38 million in FY2022 (-35.3%) and $11.41 million in FY2021.
- Quarterly Current Assets has ranged from $778,000 in Q4 2025 to $14.03 million in Q1 2022 over the past five years.
- On a year-over-year basis, Current Assets rose in 1 of the last five quarters, with an average decline of 33.1%.
- Peak year-over-year performance for Current Assets in the last five years was growth of 51.0% in Q4 2024, against a decline of 84.6% in Q3 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | NeuroSense Therapeutics | 3.19 Mn | -1.26 Mn | - | 844,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 844,000.00 |
| Dec 31, 2025 | 778,000.00 |
| Jun 30, 2025 | 1.56 Mn |
| Dec 31, 2024 | 4.40 Mn |
| Sep 30, 2024 | 785,000.00 |
| Jun 30, 2024 | 1.62 Mn |
| Mar 31, 2024 | 1.19 Mn |
| Dec 31, 2023 | 2.92 Mn |
| Sep 30, 2023 | 5.11 Mn |
| Jun 30, 2023 | 7.56 Mn |
| Mar 31, 2023 | 5.02 Mn |
| Dec 31, 2022 | 7.38 Mn |
| Sep 30, 2022 | 8.89 Mn |
| Jun 30, 2022 | 11.10 Mn |
| Mar 31, 2022 | 14.03 Mn |
| Dec 31, 2021 | 11.41 Mn |
| Dec 31, 2020 | 766,000.00 |
API Access
NeuroSense Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();